Bulk Manufacturer of Controlled Substances Application: Stepan Company, 10466 [2020-03618]

Download as PDF 10466 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices Controlled substance Drug code Alphamethadol ................................................................................................................................................................. Benzethidine .................................................................................................................................................................... Betacetylmethadol ........................................................................................................................................................... Clonitazene ...................................................................................................................................................................... Diampromide ................................................................................................................................................................... Diethylthiambutene .......................................................................................................................................................... Dimethylthiambutene ....................................................................................................................................................... Ketobemidone .................................................................................................................................................................. Levo-alphacetylmethadol ................................................................................................................................................. 1-Methyl-4-phenyl-4-propionoxypiperidine ...................................................................................................................... 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine .............................................................................................................. Alfentanil .......................................................................................................................................................................... Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Tilidine ............................................................................................................................................................................. Tapentadol ....................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... Para-Fluorofentanyl ......................................................................................................................................................... 3-Methylfentanyl .............................................................................................................................................................. Alpha-methylfentanyl ....................................................................................................................................................... Acetyl-alpha-methylfentanyl ............................................................................................................................................. Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) ............................................................................... Beta-hydroxyfentanyl ....................................................................................................................................................... Beta-hydroxy-3-methylfentanyl ........................................................................................................................................ Alpha-methylthiofentanyl ................................................................................................................................................. 3-Methylthiofentanyl ......................................................................................................................................................... Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) ............................................................. Thiofentanyl ..................................................................................................................................................................... N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide .......................................................................... Cyclopropyl Fentanyl ....................................................................................................................................................... Fentanyl related-compounds as defined in 21 CFR 1308.11&h) ................................................................................... Morrissette Drive, Springfield, Virginia 22152. The company plans to manufacture the above-listed controlled substances as analytical reference standards for distribution to its customers. No other activities for these drug codes are authorized for this registration. In accordance with 21 CFR 1301.33(a), this is notice that on December 18, 2019, Stepan Company, 100 West Hunter Avenue, Maywood, New Jersey 07607– 1021 applied to be registered as a bulk manufacturer of the following basic class of controlled substances: SUPPLEMENTARY INFORMATION: Dated: February 3, 2020. William T. McDermott, Assistant Administrator. [FR Doc. 2020–03616 Filed 2–21–20; 8:45 am] BILLING CODE 4410–09–P Drug code Controlled substance DEPARTMENT OF JUSTICE Cocaine ........................ Ecgonine ....................... Drug Enforcement Administration [Docket No. DEA–580] lotter on DSKBCFDHB2PROD with NOTICES Dated: February 3, 2020. William T. McDermott, Assistant Administrator. Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 24, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 DATES: VerDate Sep<11>2014 18:30 Feb 21, 2020 Jkt 250001 I II II The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers. Bulk Manufacturer of Controlled Substances Application: Stepan Company ACTION: I 9041 9180 Schedule [FR Doc. 2020–03618 Filed 2–21–20; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 9605 9606 9607 9612 9615 9616 9619 9628 9648 9661 9663 9737 9739 9740 9743 9750 9780 9801 9812 9813 9814 9815 9821 9830 9831 9832 9833 9834 9835 9843 9845 9850 Schedule I I I I I I I I II I I II II II II I II II I I I I I I I I I I I I I I DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–586] Importer of Controlled Substances Application: Research Triangle Institute ACTION: Notice of application. Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 25, 2020. Such persons may also file a written request for a hearing on the application on or before March 25, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, DATES: E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Page 10466]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03618]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-580]


Bulk Manufacturer of Controlled Substances Application: Stepan 
Company

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before April 24, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on December 18, 2019, Stepan Company, 100 West Hunter 
Avenue, Maywood, New Jersey 07607-1021 applied to be registered as a 
bulk manufacturer of the following basic class of controlled 
substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Cocaine................................     9041  II
Ecgonine...............................     9180  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances in bulk for distribution to its customers.

    Dated: February 3, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-03618 Filed 2-21-20; 8:45 am]
BILLING CODE 4410-09-P